Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: Sam who wrote (208927)	8/18/2021 12:24:48 PM
From: i-node	Read Replies (1) \| Respond to of 363139

I posted a legitimate study that found high-dose HCQ with AZ produced 200% better survival in severely ill patients. That was a significant finding and one that perhaps ought to not be discounted. You're free to draw your own conclusions from the study. You can easily find it on google. Or here is a direct link if you actually want to READ THE FUCKING STUDY. Observational Study on 255 Mechanically Ventilated Covid Patients at the Beginning of the USA Pandemic (medrxiv.org) While a 200% increase in survival is significant, it is not the kind of near 100% recovery you get with early treatment. And there is no evidence HcQ can save a patient once the cytokine storm is underway in full force. As usual, you desperate fuck, you're trying to bend my posts into something you want it to be. You're not an honest person, and I prefer not to engage you. But I do have to admit that when you come to this thread you really don't expect much honesty.